ATRC - AtriCure Inc. (ATRC) Q2 2024 Earnings Call Transcript
2024-07-31 00:01:03 ET
AtriCure, Inc. (ATRC)
Q2 2024 Earnings Conference Call
July 30, 2024, 04:30 PM ET
Company Participants
Marissa Bych - Investor Relations
Michael Carrel - President and Chief Executive Officer
Angela Wirick - Chief Financial Officer
Conference Call Participants
Lilia Lozada - JPMorgan
John Newman - Canaccord Genuity
John McAulay - Stifel Financial Corp.
Sam Eiber - BTIG
Danielle Antalffy - UBS
Daniel Stauder - Citizens JMP
Suraj Kalia - Oppenheimer & Co.
Joseph Conway - Needham & Company
Presentation
Operator
Good afternoon, And welcome to AtriCure's Second Quarter 2024 Earnings Conference Call. This call is being recorded for replay purposes. [Operator Instructions]
I would now like to turn the call over to Marissa Bych, from the Gilmartin Group for a few introductory comments.
Marissa Bych
Great. Thank you, operator. By now, you should have received a copy of the earnings press release. If you have not received a copy, please call (513) 644 4484 to have one e-mailed to you.
Before we begin today, let me remind you that the company's remarks include forward-looking statements. Forward-looking statements are subject to numerous risks and uncertainties, many of which are beyond AtriCure's control, including risks and uncertainties described from time to time in AtriCure's SEC filings. These statements include, but are not limited to, financial expectations and guidance, expectations regarding the potential market opportunity for AtriCure franchises and growth initiatives, future product approvals, clearances, competition, reimbursement and clinical trial outcomes. AtriCure's results may differ materially from those projected....
AtriCure, Inc. (ATRC) Q2 2024 Earnings Call Transcript